Genome Research Limited (Wellcome Trust Sanger Institute)
The Wellcome Trust Sanger Institute is a not-for-profit research organisation and is one of the world's leading genome centres. The Institute uses genome sequences to advance understanding of the biology of humans and pathogens in order to improve human health. Funded principally by the Wellcome Trust, its scientists conduct research at scale, engaging in bold and long-term exploratory projects that are designed to influence and empower medical science globally.
Key staff involved in EBiSC
Dr Ludovic Vallier – uses human pluripotent stem cells - cells with the ability to develop into almost any type of cell in the body - to study how biological mechanisms direct them to become a pancreas or liver cell. He is also investigating the role these mechanisms play in diabetes and other metabolic disorders.
Ludovic is now Reader in Stem Cells and Regenerative Medicine and member of the Cambridge Stem Cell Institute. He is also the director of the Cambridge National Institute for Health Research (NIHR)/Biomedical Research Centre HiPSC (human induced pluripotent stem cell) core facility.
Ludovic joined the Sanger Institute in 2012 as a member of Faculty with a joint appointment with Cambridge University. He is studying the genetic mechanisms that control pancreas and liver development to uncover new targets for treating metabolic disorders such as diabetes. (Click here for more information about Ludovic Vallier).
More information: www.sanger.ac.uk »